Forte Biosciences, Inc. (FBRX)
FBRX · Pharmaceutical Preparations · Dallas, TX · filing with the SEC since 2007
Who owns Forte Biosciences, Inc.
As filed with the SECHolders of 5% or more
6
Tybourne Capital Management (Hk) Ltd holds 9.99% of Common Stock, as its SCHEDULE 13G/A filed Aug 4, 2025 says.
Directors and officers
9
report now, of 26 people on the record since 2017. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 6 named at left.
Holders of 5% or moreshare of the class, as filed
Tybourne Capital Management (Hk) Ltd
SCHEDULE 13G/A · filed Aug 4, 2025 · Common Stock · 9.99% in Feb 14, 2025
JANUS HENDERSON GROUP Ltd.
SCHEDULE 13G/A · filed Aug 13, 2026 · Common Stock · 2.5% in Aug 7, 2026
MPM BioImpact LLC
SCHEDULE 13G · filed May 15, 2026 · Common Stock, par value $0.001 per share
Orbimed Advisors LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.001 per share · 4.3% in May 15, 2026
Blackrock, Inc.
SCHEDULE 13G · filed Jul 28, 2026 · Common Stock
Affinity Asset Advisors, LLC
SCHEDULE 13G/A · filed Aug 13, 2026 · Common Stock, par value $0.001 per share · 7.3% in May 14, 2026
Ikarian Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2025 · Common Stock, $0.001 par value · reported falling below 5%, from 9.5% in Feb 14, 2025
Alger Associates, Inc.
SCHEDULE 13G/A · filed Aug 7, 2026 · Common Stock · reported falling below 5%, from 10.2% in May 15, 2026
Adage Capital Management, L.P.
SCHEDULE 13G/A · filed Aug 12, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 6.84% in May 13, 2026
Dapice Joshua J.
SCHEDULE 13G/A · filed Feb 10, 2025 · Common Stock, par value $0.001 per share (the "Shares") · reported falling below 5%
Millennium Management LLC
SCHEDULE 13G/A · filed Jul 16, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 5.2% in Jun 8, 2026
Perceptive Advisors LLC
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock, par value $0.001 per share · reported falling below 5%
Oliveira Steven Michael
SCHEDULE 13G/A · filed Jan 9, 2026 · Common Stock, $0.001 par value · reported falling below 5%, from 6.76% in Jan 10, 2025
Glazer Capital, LLC
SCHEDULE 13G · filed Aug 11, 2026 · Common Stock · reported falling below 5%
Boothbay Fund Management, LLC
SCHEDULE 13G/A · filed Aug 7, 2025 · Common Stock, $0.001 par value per share · reported falling below 5%, from 6% in Feb 13, 2025
Bvf Gp Holdings LLC
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock, $0.001 par value · reported falling below 5%, from 9.99% in Feb 14, 2025
Federated Hermes, Inc.
SCHEDULE 13G/A · filed Sep 8, 2026 · COMMON STOCK · reported falling below 5%, from 10.3% in Jul 8, 2026
Point72 Asset Management, L.P.
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.001 per share · reported falling below 5%, from 6.3% in Jan 20, 2026
What FBRX reports owning in othersstakes of 5% or more, and other ties
2 subsidiaries in 2 countries, from the list filed with the 10-K filed Mar 28, 2025.
Insider tradesForm 4
0sales
1purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$300,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window1 of 27 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Riley Antony A | CHIEF FINANCIAL OFFICER | 0 | $0 | 0 | 1 | $300,000 |